HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 18 of 18
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
article (author version)Furuta, Megumi; Sakakibara-Konishi, Jun; Kikuchi, Hajime; Yokouchi, Hiroshi; Nishihara, Hiroshi; Minemura, Hiroyuki; Harada, Masao; Yamazaki, Shigeo; Akie, Kenji; Fujita, Yuka; Takamura, Kei; Kojima, Tetsuya; Harada, Toshiyuki; Minami, Yoshinori; Watanabe, Naomi; Oizumi, Satoshi; Suzuki, Hiroyuki; Nishimura, Masaharu; Dosaka-Akita, Hirotoshi; Isobe, HiroshiAnalysis of DLL3 and ASCL1 in Surgically Resected Small Cell Lung Cancer (HOT1702)-The Oncologist-Nov-2019
articleShimizu, Junichi; Masago, Katsuhiro; Saito, Haruhiro; Nishino, Kazumi; Kurata, Takayasu; Itoh, Yohji; Yoshimura, Yoko; Yabuki, Yutaka; Dosaka-Akita, HirotoshiBiomarker testing for personalized, first-line therapy in advanced nonsquamous non-small cell lung cancer patients in the real world setting in Japan: a retrospective, multicenter, observational study (the BRAVE study)-Therapeutic advances in medical oncology-Feb-2020
article (author version)Takashima, Yuta; Kikuchi, Eiki; Kikuchi, Junko; Suzuki, Motofumi; Kikuchi, Hajime; Maeda, Makie; Shoji, Tetsuaki; Furuta, Megumi; Kinoshita, Ichiro; Dosaka-Akita, Hirotoshi; Sakakibara-Konishi, Jun; Konno, SatoshiBromodomain and extraterminal domain inhibition synergizes with WEE1-inhibitor AZD1775 effect by impairing nonhomologous end joining and enhancing DNA damage in nonsmall cell lung cancer-International journal of cancer-15-Feb-2020
article (author version)Takashima, Yuta; Sakakibara-Konishi, Jun; Hatanaka, Yutaka; Hatanaka, Kanako C.; Ohhara, Yoshihito; Oizumi, Satoshi; Hida, Yasuhiro; Kaga, Kichizo; Kinoshita, Ichiro; Dosaka-Akita, Hirotoshi; Matsuno, Yoshihiro; Nishimura, MasaharuClinicopathologic Features and Immune Microenvironment of Non-Small-cell Lung Cancer With Primary Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors-Clinical lung cancer-Jul-2018
articleTakashina, Taichi; Kinoshita, Ichiro; Kikuchi, Junko; Shimizu, Yasushi; Sakakibara-Konishi, Jun; Oizumi, Satoshi; Nishimura, Masaharu; Dosaka-Akita, HirotoshiCombined inhibition of EZH2 and histone deacetylases as a potential epigenetic therapy for non-small-cell lung cancer cells-Cancer science-Jul-2016
articleTakeuchi, Satoshi; Shiga, Tohru; Hirata, Kenji; Taguchi, Jun; Magota, Keiichi; Ariga, Shin; Gouda, Tomohiro; Ohhara, Yoshihito; Homma, Rio; Shimizu, Yasushi; Kinoshita, Ichiro; Tsuji, Yasushi; Homma, Akihiro; Iijima, Hiroaki; Tamaki, Nagara; Dosaka-Akita, HirotoshiEarly prediction of lenvatinib treatment efficacy by using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma that is refractory to radioiodine treatment : a protocol for a non-randomized single-arm multicenter observational study-BMJ Open-Nov-2018
articleShiiya, Akihiko; Noguchi, Takuro; Tomaru, Utano; Ariga, Shin; Takashima, Yuta; Ohhara, Yoshihito; Taguchi, Jun; Takeuchi, Satoshi; Shimizu, Yasushi; Kinoshita, Ichiro; Koizumi, Tomonobu; Matsuno, Yoshihiro; Shinagawa, Naofumi; Sakakibara-Konishi, Jun; Dosaka-Akita, HirotoshiEGFR inhibition in EGFR-mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironment-Cancer science-Apr-2023
article (author version)Shoji, Tetsuaki; Kikuchi, Eiki; Kikuchi, Junko; Takashima, Yuta; Furuta, Megumi; Takahashi, Hirofumi; Tsuji, Kosuke; Maeda, Makie; Kinoshita, Ichiro; Dosaka-Akita, Hirotoshi; Sakakibara-Konishi, Jun; Konno, SatoshiEvaluating the immunoproteasome as a potential therapeutic target in cisplatin-resistant small cell and non-small cell lung cancer-Cancer chemotherapy and pharmacology-May-2020
articleKikuchi, Hajime; Sakakibara-Konishi, Jun; Furuta, Megumi; Yokouchi, Hiroshi; Nishihara, Hiroshi; Yamazaki, Shigeo; Uramoto, Hidetaka; Tanaka, Fumihiro; Harada, Masao; Akie, Kenji; Sugaya, Fumiko; Fujita, Yuka; Takamura, Kei; Kojima, Tetsuya; Harada, Toshiyuki; Higuchi, Mitsunori; Honjo, Osamu; Minami, Yoshinori; Watanabe, Naomi; Oizumi, Satoshi; Suzuki, Hiroyuki; Ishida, Takashi; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Munakata, Mitsuru; Nishimura, MasaharuExpression of Notch1 and Numb in small cell lung cancer-Oncotarget-7-Feb-2017
article (author version)Mizumachi, Takatsugu; Homma, Akihiro; Kakizaki, Tomohiko; Sakashita, Tomohiro; Kano, Satoshi; Hatakeyama, Hiromitsu; Tsuchiya, Kazuhiko; Yasuda, Koichi; Onimaru, Rikiya; Shirato, Hiroki; Taguchi, Jun; Shimizu, Yasushi; Kinoshita, Ichiro; Akita, Hirotoshi; Fukuda, SatoshiFeasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma-International journal of clinical oncology-Jun-2015
articleHontani, Koji; Tsuchikawa, Takahiro; Hiwasa, Takaki; Nakamura, Toru; Ueno, Takashi; Kushibiki, Toshihiro; Takahashi, Mizuna; Inoko, Kazuho; Takano, Hironobu; Takeuchi, Satoshi; Dosaka-Akita, Hirotoshi; Kuwatani, Masaki; Sakamoto, Naoya; Hatanaka, Yutaka; Mitsuhashi, Tomoko; Shimada, Hideaki; Shichinohe, Toshiaki; Hirano, SatoshiIdentification of novel serum autoantibodies against EID3 in non-functional pancreatic neuroendocrine tumors-Oncotarget-5-Dec-2017
articleTakeuchi, Satoshi; Goda, Tomohiro; Taguchi, Jun; Douhata, Yuichi; Honma, Rio; Ariga, Shin; Ohhara, Yoshihito; Shimizu, Yasushi; Kinoshita, Ichiro; Fukuda, Izumi; Nagashima, Yoji; Akita, HirotoshiLate Onset of Non-islet Cell Tumor Hypoglycemia Managed via Multidisciplinary Treatment in a Patient with a Solitary Fibrous Tumor-Internal medicine-15-Aug-2018
article (author version)Sakakibara-Konishi, Jun; Oizumi, Satoshi; Kinoshita, Ichiro; Shinagawa, Naofumi; Kikuchi, Junko; Kato, Mototsugu; Inoue, Tetsuya; Katoh, Norio; Onimaru, Rikiya; Shirato, Hiroki; Dosaka-Akita, Hirotoshi; Nishimura, MasaharuPhase I study of concurrent real-time tumor-tracking thoracic radiation therapy with paclitaxel and carboplatin in locally advanced non-small cell lung cancer-Lung Cancer-Nov-2011
article (author version)Takashina, Taichi; Asahina, Hajime; Oizumi, Satoshi; Yamada, Noriyuki; Harada, Masao; Takamura, Kei; Yokouchi, Hiroshi; Harada, Toshiyuki; Honjo, Osamu; Ogi, Takahiro; Morikawa, Naoto; Kinoshita, Ichiro; Honda, Ryoichi; Nakano, Kosuke; Kanazawa, Kenya; Amano, Toraji; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, MasaharuA phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101)-International journal of clinical oncology-Dec-2018
article (author version)Asahina, Hajime; Oizumi, Satoshi; Inoue, Akira; Kinoshita, Ichiro; Ishida, Takashi; Fujita, Yuka; Sukoh, Noriaki; Harada, Masao; Maemondo, Makoto; Saijo, Yasuo; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nukiwa, Toshihiro; Nishimura, MasaharuPhase II Study of Gefitinib Readministration in Patients with Advanced Non-Small Cell Lung Cancer and Previous Response to Gefitinib-Oncology : International Journal for Cancer Research and Treatment-Apr-2011
article (author version)Ito, Shotaro; Asahina, Hajime; Honjo, Osamu; Tanaka, Hisashi; Honda, Ryoichi; Oizumi, Satoshi; Nakamura, Keiichi; Takamura, Kei; Hommura, Fumihiro; Kawai, Yasutaka; Ito, Kenichiro; Sukoh, Noriaki; Yokoo, Keiki; Morita, Ryo; Harada, Toshiyuki; Takashina, Taichi; Goda, Tomohiro; Dosaka-Akita, Hirotoshi; Isobe, HiroshiPrognostic factors in patients with advanced non-small cell lung cancer after long-term Anti-PD-1 therapy (HOT1902)-Lung cancer-Jun-2021
article (author version)Asahina, Hajime; Oizumi, Satoshi; Takamura, Kei; Harada, Toshiyuki; Harada, Masao; Yokouchi, Hiroshi; Kanazawa, Kenya; Fujita, Yuka; Kojima, Tetsuya; Sugaya, Fumiko; Tanaka, Hisashi; Honda, Ryoichi; Kikuchi, Eiki; Ikari, Tomoo; Ogi, Takahiro; Shimizu, Kaoruko; Suzuki, Masaru; Konno, Satoshi; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, MasaharuA prospective phase II study of carboplatin and nab-paclitaxel in patients with advanced non-small cell lung cancer and concomitant interstitial lung disease (HOT1302)-Lung cancer-Dec-2019
article (author version)Ikezawa, Yasuyuki; Asahina, Hajime; Oizumi, Satoshi; Watanabe, Masahiro; Takamura, Kei; Kawai, Yasutaka; Yamada, Noriyuki; Harada, Toshiyuki; Kinoshita, Ichiro; Fujita, Yuka; Miyauchi, Eisaku; Ogi, Takahiro; Amano, Toraji; Furuta, Megumi; Sakakibara-Konishi, Jun; Nishihara, Hiroshi; Dosaka-Akita, Hirotoshi; Isobe, Hiroshi; Nishimura, MasaharuA randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)A randomized phase II trial of erlotinib versus S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002)Cancer chemotherapy and pharmacology-Nov-2017
Showing results 1 to 18 of 18

 

Hokkaido University